A Note on Safety We built medicinal-use.com to help make sense of the UK’s changing laws, but we aren’t doctors. This content is for research and education—it isn’t medical advice. Before changing your healthcare routine or starting a new treatment, please speak with a GMC-registered clinician. Your safety matters more than any article we write.
[my_disclaimer]
CBD (cannabidiol) and THC (tetrahydrocannabinol) are the two most well-known cannabinoids in cannabis. They have different effects, legal status, and availability in the UK. This guide compares them, explains common product forms, and outlines what patients can access in 2025.
1. CBD vs THC – Key Differences
| Aspect | CBD (Cannabidiol) | THC (Tetrahydrocannabinol) |
|---|---|---|
| Psychoactive? | No – does not cause a high | Yes – causes euphoria, altered perception |
| Main Effects | Calming, anti-anxiety, anti-inflammatory, may improve sleep quality | Pain relief, appetite stimulation, sleep onset, potential anti-nausea |
| Anxiety Impact | Often reduces anxiety (dose-dependent) | Can reduce (low dose) or increase (high dose) |
| Legal Status (UK) | Legal if <0.2% THC and meets FSA novel foods rules (non-medicinal claims only) | Schedule 2 controlled drug – prescription only (CBPMs) |
| Common Sources | Hemp-derived, broad/full-spectrum oils | Cannabis plant (medical flower, oils, sprays) |
| Risk of Dependence | Very low | Moderate (especially with regular high-THC use) |
| Driving Risk | Minimal (no impairment) | High – impairment windows apply (DVLA rules) |
Summary: CBD is non-intoxicating and widely available over-the-counter (non-medicinal). THC is psychoactive, prescription-only in medical form, and carries higher risks but also stronger potential benefits for certain symptoms.
2. Product Types Available in the UK 2025
Non-Prescription (Over-the-Counter / Non-Medicinal)
- CBD Oils, Capsules, Gummies, Topicals
- Legal if: <0.2% THC, compliant with Food Standards Agency novel foods authorisation (many brands now authorised).
- No medicinal claims allowed (ASA rules).
- Typical strength: 500–2000 mg CBD per bottle.
- Common uses: General wellness, relaxation, mild anxiety/sleep support (anecdotal).
- Hemp-Derived Products
- Broad-spectrum (THC removed) or full-spectrum (<0.2% THC).
- Widely sold in health shops, online, pharmacies.
Prescription-Only (CBPMs)
- CBD-Dominant Oils/Capsules
- High CBD, very low/no THC.
- Prescribed for anxiety, sleep, epilepsy, etc.
- Examples: Adven, Celixir, Grow Pharma products.
- Balanced THC/CBD Oils & Capsules
- Equal or near-equal ratios (e.g., 1:1 or 10:10).
- Used for pain, sleep, anxiety, MS spasticity.
- Common in private clinics.
- THC-Dominant Flower (Vaporised)
- Dried cannabis flower (EU-GMP standard).
- Used for pain, nausea, appetite.
- Requires vaporiser (not smoked).
- THC/CBD Sprays
- Similar to Sativex (licensed for MS spasticity).
- Prescription for specific indications.
3. How Patients Choose CBD vs THC Products
- CBD-dominant first — Clinics often start here for anxiety, sleep, or mild symptoms (lower risk profile).
- Add THC — If CBD alone insufficient for pain, nausea, or severe sleep issues.
- Balanced — Most common for chronic conditions (balances benefits/risks).
- Titration — Start low, go slow, adjust under specialist supervision.
4. Risks and Considerations
- CBD — Generally well-tolerated; possible fatigue, diarrhoea, appetite changes. Drug interactions possible (e.g., with blood thinners).
- THC — Anxiety/paranoia (high doses), dependence, cognitive impairment, rebound insomnia on cessation. Driving impairment (DVLA rules strict).
- General — Quality varies; only use licensed pharmacies for CBPMs. Avoid unregulated black-market products.
Sources
- MHRA guidance on CBPMs
- FSA novel foods list for CBD
- GMC specialist prescribing rules
- UK Medical Cannabis Registry product data
- ASA/CAP rules on CBD claims